Technology News and Research

RSS

Austin Retina partners with MVRF to sponsor SupportSight seminar

Austin Retina Associates has joined with the Macula Vision Research Foundation (MVRF) to sponsor a SupportSight seminar in Austin on October 3rd. SupportSight is the national series of educational seminars for people affected by macular degeneration and for those who would like to learn more about this disease affecting more than 25 million people in this country.

22 Sep 2009

China SFDA awards Jiangsu Yanshen a new drug certificate and production license for its H1N1 vaccine

Simcere Pharmaceutical Group (NYSE: SCR) ("Simcere" or the "Company"), a leading manufacturer and supplier of branded generic and innovative pharmaceuticals in China, today announced that Jiangsu Yanshen Biological Technology Stock Co., Ltd ("Jiangsu Yanshen"), in which Simcere holds a 37.5% stake, was awarded a new drug certificate and production license from China's State Food and Drug Administration (SFDA) on September 18 for Jiangsu Yanshen's H1N1 vaccine.

22 Sep 2009

Emissary Capital begins investment research coverage on Sinobiopharma

Emissary Capital Group, Inc. has initiated investment research coverage on Sinobiopharma, Inc. (OTC Bulletin Board: SNBP) with a Buy rating and target price of $1.00-$1.25.

22 Sep 2009

Gerresheimer opens new R&D and production centers in USA and Europe

The Gerresheimer Group expands its activities in the pharmaceutical plastic business with two strategically significant investments in the USA and Europe. This week the company is almost simultaneously opening a new research and development center for medical plastic systems in the USA as well as a new production center for pharmaceutical plastic packaging in Spain.

22 Sep 2009

Model-Based Design reduces the development time of FES devices

The MathWorks today announced that the Cleveland FES Center, using tools for Model-Based Design, has developed research technology that more quickly restores movement to individuals with neuromuscular disabilities.

22 Sep 2009

ID-ONE Cosmo dual interface card for multiple secure applications launched by Oberthur Technologies

Oberthur Technologies, a global leader in the delivery of high security solutions and the #1 provider of credentials to the U.S. Federal government, announces the availability of its dual interface ID-ONE™ Cosmo card to the Corporate Market at the ASIS International 55th Annual Seminar, September 21-24 at the Anaheim Convention Center in Anaheim, CA.

22 Sep 2009

PMCC purchases NextGen EHR and EPM software licenses

NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and a leading provider of ambulatory healthcare and connectivity solutions, today announced that Piedmont Medical Care Corporation (PMCC), the administrative arm of the non-cardiology physician practice entities of Piedmont Healthcare (PHC), has purchased an additional 230 “bundled” NextGen Electronic Health Record (EHR) and NextGen Enterprise Practice Management (EPM) software licenses.

22 Sep 2009

T-System revises its H1N1 point-of-care charting templates

T-System, Inc., the nation's largest provider of emergency department (ED) clinical documentation tools, today announced it has issued revised H1N1 point-of-care charting templates reflecting the most recent recommendations of the Centers for Disease Control and Prevention (CDC).

22 Sep 2009

StemCells to take part in international networking event

StemCells, Inc. (NASDAQ:STEM) announced today its participation in the 2009 World Stem Cell Summit to be held September 21 – 23 in Baltimore, Maryland.

22 Sep 2009

Sentillion to participate in National Health IT Week's Technology Showcase

As part of their efforts to improve the effectiveness of both security and clinical workflows in the healthcare delivery process, Sentillion, whose identity and access management (IAM) solutions are the most widely implemented in healthcare, today announced their participation in the “Steering Committee on Telehealth and Healthcare Informatics” Healthcare Information Technology Showcase on Thursday, September 24th on Capitol Hill. The Technology Showcase is part of the activities of “National Health IT Week” going on September 21st – 25th in Washington DC.

22 Sep 2009

Data show a decrease in ozone layer

By merging more than a decade of atmospheric data from European satellites, scientists have compiled a homogeneous long-term ozone record that allows them to monitor total ozone trends on a global scale - and the findings look promising.

22 Sep 2009

New sirolimus-eluting stent shows greater neointimal suppression than PES

A new type of sirolimus-eluting stent (SES) successfully showed significantly greater neointimal suppression than the paclitaxel-eluting stent (PES) with greater vessel wall integrity surrounding the stent, confirming the finding of superiority of the SES over the PES stent for the trial's primary endpoint of in-stent late loss.

22 Sep 2009

Gerresheimer opens new R&D and production centers in USA and Europe

The Gerresheimer Group expands its activities in the pharmaceutical plastic business with two strategically significant investments in the USA and Europe.

22 Sep 2009

Health Robotics chooses Device Technologies Australia as its exclusive CytoCare partner for Oceania

Health Robotics today announced that it has signed an exclusive five-year strategic partnership with Device Technologies Australia Pty Ltd. for its revolutionary CytoCare(TM) Robot. This strategic agreement enables Device Technologies Australia to achieve its goal of safely, accurately and cost-effectively automating the preparation of Oncology I.V. Admixtures to complement its other market-leading Oncology and Surgery Robotic solutions.

22 Sep 2009

Winners of the 2009 Biotechnology Vision Summit's Emerging Company Showcase announced

Six Wisconsin biotechnology companies have been selected the winners of the first Emerging Company Showcase. The showcase is part of the Biotechnology Vision Summit 2009, being held on Wednesday, Oct. 7, at the Madison Marriott West in Madison, Wis. The summit and the showcase are being hosted by BioForward, the member-driven state association that is the voice of Wisconsin’s biotechnology industry.

22 Sep 2009

Antigen to block infection by genetically-diverse strains of HIV

Scientists working to develop a vaccine for the human immunodeficiency virus (HIV) report they have created the first antigen that induces protective antibodies capable of blocking infection of human cells by genetically-diverse strains of HIV. The new antigen differs from previously-tested vaccines by virtue of its chemically-activated property that enables close sharing of electrons and produces strong covalent bonding.

22 Sep 2009

Industrial lipases launched by EUCODIS Bioscience

EUCODIS Bioscience, a company developing, customizing, manufacturing, and marketing enzymes for the chemical industry, announced today that it has launched the first enzymes of its lipase portfolio. EUCODIS Bioscience currently offers 12 lipases that have been selected to cover a broad range of potential industrial applications.

22 Sep 2009

Moses Cone Health System installs TomoTherapy cancer treatment system

TomoTherapy Incorporated announced today that Moses Cone Health System has installed North Carolina's first TomoTherapy® cancer treatment system at the Moses Cone Regional Cancer Center in Greensboro, N.C.

22 Sep 2009

T-M-Partners chooses InterSystems Ensemble for its CMS Quality Manager healthcare application

InterSystems Corporation today announced that Technology Medical Partners (T-M-Partners) has selected the InterSystems Ensemble® rapid integration and development platform for its CMS Quality Manager healthcare application. The first of many healthcare technology solutions under development by T-M-Partners, CMS Quality Manager is designed to vastly improve the data abstraction and administrative processes of reporting core measures to the Centers for Medicaid and Medicare Services (CMS).

22 Sep 2009

U.S. HHS orders for an additional 29 million doses of MedImmune's influenza vaccine

MedImmune announced today that the U.S. Department of Health and Human Services (HHS) has placed an order for an additional 29 million doses of its live attenuated influenza vaccine (LAIV) against the 2009 H1N1 influenza virus. This brings HHS orders to date to more than 40 million vaccine doses, with a total cumulative contract value of approximately $453 million.

22 Sep 2009